Peroral Endoscopic Myotomy for Treating Achalasia Performed by a Gastroenterologist: 4 Yearsʼ Experience from a Single Endoscopy Center

Wei Gong,Xiaowei Tang,Silin Huang,Yutang Ren,Jieqiong Zhou,Qiaoping Gao,Xiaofeng Zhang,Bo Jiang
DOI: https://doi.org/10.14309/00000434-201610001-00398
2016-01-01
Abstract:Introduction: Esophageal achalasia is most commonly treated with endoscopic dilation or laparoscopic Heller myotomy. Peroral endoscopic myotomy (POEM) has recently been described as a novel treatment for achalasia in humans. The aim of this study was to assess the clinical effectiveness and safety of POEM for treating esophageal achalasia performed by a gastroenterologist in a single endoscopic center within 4 years.Table 1: Baseline and clinical characteristics of patientsTable 2: Clinical outcomes of POEM procedureMethods: Between June 2011 to November 2015, POEM was performed in 153 consecutive patients with achalasia. POEM procedure consisted of the following step: firstly, submucosal tunnel was created and extended below the lower esophageal sphincter (LES) onto the gastric cardia after a mucosal incision was made; then endoscopic myotomy of circular muscle bundles was done; finally, the mucosal entry was closed by hemostatic clips (Figure 1). The Eckardt score and manometry were used to evaluate the outcomes.Figure 1Results: POEM was successfully performed in all cases. Mean procedure time was 51.3 ± 16.6 min and mean myotomy length was 8.4 ± 3.3 cm. Mucosal perforations occurred in 6 (3.9%) patients during submucosal tunnel creation, major bleeding occurred in 9 (5.9%) patients, and 7 (4.6%) patients suffered pneumothorax immediate after procedure. All the complications were managed conservatively. During a mean follow-up period of 25 months (range 6-59.4 months), 20 patients were lost, and treatment success was achieved in 124/133 patients (93.2%). Mean LES pressure was 45.1 mmHg and 15.3 mmHg before and after the procedure (P = 0.000), respectively. Mean Eckardt score was 8.3 and 1.4 before and after POEM, respectively (P = 0.000). 23 patient (17.3%) developed mild reflux symptoms and required intermittent medication with proton pump inhibitors during the follow-up. Conclusion: Our study demonstrated that POEM is a safe, and effective treatment for achalasia during the long-term follow-up. Further studies are warranted to compare POEM with other treatment modalities.
What problem does this paper attempt to address?